思派健康预计将于本月刊发2025财政年度全年业绩公告。该公司上月发布正面盈利预告，预期截至去年12月31日止年度净亏损较2024年将大幅收窄逾64%。主要由于集团核心业务（即企业保险服务业务及医生研究协助业务）实现强劲增长；对特药药房业务的重组取得显著成效；及透过实施多项提质增效措施使销售及行政费用率降低。
Source Link思派健康预计将于本月刊发2025财政年度全年业绩公告。该公司上月发布正面盈利预告，预期截至去年12月31日止年度净亏损较2024年将大幅收窄逾64%。主要由于集团核心业务（即企业保险服务业务及医生研究协助业务）实现强劲增长；对特药药房业务的重组取得显著成效；及透过实施多项提质增效措施使销售及行政费用率降低。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.